株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

麻酔・呼吸器関連デバイスの世界市場 - 製品(麻酔用デバイス、呼吸器用デバイス)、地域別の予測 2019年~2026年

Anesthesia & Respiratory Devices Market Size, Share & Trends Analysis Report By Product (Anesthesia Devices, Respiratory Devices), By Region, And Segment Forecasts, 2019 - 2026

発行 Grand View Research, Inc. 商品コード 851702
出版日 ページ情報 英文 125 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
麻酔・呼吸器関連デバイスの世界市場 - 製品(麻酔用デバイス、呼吸器用デバイス)、地域別の予測 2019年~2026年 Anesthesia & Respiratory Devices Market Size, Share & Trends Analysis Report By Product (Anesthesia Devices, Respiratory Devices), By Region, And Segment Forecasts, 2019 - 2026
出版日: 2019年04月16日 ページ情報: 英文 125 Pages
概要

世界の麻酔・呼吸器関連デバイス市場は、2019年から2026年にかけて6.6%のCAGRで推移し、2026年までに494億米ドル規模の市場に成長すると予測されています。呼吸器疾患の有病率の上昇、患者の入院短期化の傾向、政府支援などが当市場の主な成長要因となっています。

当レポートでは、世界の麻酔・呼吸器関連デバイス市場を調査し、市場の概要、製品・地域別の市場規模の推移と予測、市場の成長要因および阻害要因、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査手法と範囲

  • 市場区分と範囲
  • 情報調達
  • 情報分析
  • 市場形成とデータの可視化
  • データ検証と公開

第2章 エグゼクティブサマリー

  • 市場の見通し
  • 市場の見通し
  • 競争の考察

第3章 市場変数、動向、範囲

  • 市場リネージュの見通し
  • 浸透および成長の見通しのマッピング
  • パイプライン分析:段階別
  • 主要エンドユーザー:国・地域・製品別
  • 規制の枠組み
  • 市場力学
  • 市場分析ツール

第4章 麻酔・呼吸器関連デバイス市場の分析:製品別

  • 定義と範囲
  • 市場シェア:製品別(実績値・予測値)
  • セグメントダッシュボード
  • 市場分析:製品別
  • 市場規模の推移と予測:製品別

第5章 麻酔・呼吸器関連デバイス市場の分析:地域別

  • 定義と範囲
  • 市場シェア:製品別(実績値・予測値)
  • セグメントダッシュボード
  • 市場スナップショット:地域別
  • 市場シェアと主要企業:地域別
  • SWOT分析
  • 市場規模の推移と予測:地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中南米
    • 中東・アフリカ

第6章 競合分析

  • 近年の動向と影響の分析:参入企業別
  • 企業区分(革新的企業、マーケットリーダー、新興企業)
  • ベンダー情勢
  • 公開会社
  • 民間企業
  • サプライヤーランキング
  • 主要企業のプロファイル
図表

List of Tables

  • TABLE 1 Global anesthesia and respiratory devices market, by region, 2015 - 2026 (USD Million)
  • TABLE 2 Global anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 3 North America anesthesia and respiratory devices market, by region, 2015 - 2026 (USD Million)
  • TABLE 4 North America anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 5 U.S. anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 6 Canada anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 7 Europe anesthesia and respiratory devices market, by region, 2015 - 2026 (USD Million)
  • TABLE 8 Europe anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 9 U.K. anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 10 Germany anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 11 Italy anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 12 France anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 13 Spain anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 14 Asia Pacific anesthesia and respiratory devices market, by region, 2015 - 2026 (USD Million)
  • TABLE 15 Asia Pacific anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 16 India anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 17 China anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 18 Japan anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 19 Australia anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 20 South Korea anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 21 Latin America anesthesia and respiratory devices market, by region, 2015 - 2026 (USD Million)
  • TABLE 22 Latin America anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 23 Brazil anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 24 Mexico anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 25 Argentina anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 26 Colombia anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 27 Middle East & Africa anesthesia and respiratory devices market, by region, 2015 - 2026 (USD Million)
  • TABLE 28 Middle East & Africa anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 29 South Africa anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 30 Saudi Arabia anesthesia and respiratory devices market, by product, 2015 - 2026 (USD Million)
  • TABLE 31 UAE anesthesia and respiratory devices Market, by product, 2015 - 2026 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Market formulation & validation
  • FIG. 8 Anesthesia and respiratory devices market segmentation
  • FIG. 9 Market driver relevance analysis (Current & future impact)
  • FIG. 10 Milk bank data
  • FIG. 11 Market restraint relevance analysis (Current & future impact)
  • FIG. 12 Penetration & growth prospect mapping
  • FIG. 13 SWOT analysis, by factor (political & legal, economic and technological)
  • FIG. 14 Porter's five forces analysis
  • FIG. 15 Ansoff matrix analysis
  • FIG. 16 Heat map analysis
  • FIG. 17 Market penetration vs growth prospect mapping
  • FIG. 18 Market share of key market players- Anesthesia and respiratory devices market
  • FIG. 19 Strategy mapping
  • FIG. 20 Anesthesia and respiratory devices market product outlook: Key takeaways
  • FIG. 21 Anesthesia and respiratory devices market: Product movement analysis
  • FIG. 22 Anesthesia devices market, 2015 - 2026 (USD Million)
  • FIG. 23 Anesthesia delivery machines market, 2015 - 2026 (USD Million)
  • FIG. 24 Anesthesia monitors market, 2015 - 2026 (USD Million)
  • FIG. 25 Anesthesia ventilators market, 2015 - 2026 (USD Million)
  • FIG. 26 Anesthesia workstations market, 2015 - 2026 (USD Million)
  • FIG. 27 Anesthesia disposables market, 2015 - 2026 (USD Million)
  • FIG. 28 Anesthesia disposables masks market, 2015 - 2026 (USD Million)
  • FIG. 29 Anesthesia disposable accessories market, 2015 - 2026 (USD Million)
  • FIG. 30 Respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 31 Positive airway pressure market, 2015 - 2026 (USD Million)
  • FIG. 32 Ventilators market, 2015 - 2026 (USD Million)
  • FIG. 33 Nebulizers market, 2015 - 2026 (USD Million)
  • FIG. 34 Humidifiers market, 2015 - 2026 (USD Million)
  • FIG. 35 Respiratory inhalers market, 2015 - 2026 (USD Million)
  • FIG. 36 Oxygen concentrators masks market, 2015 - 2026 (USD Million)
  • FIG. 37 Reusable resuscitators market, 2015 - 2026 (USD Million)
  • FIG. 38 Respiratory disposables market, 2015 - 2026 (USD Million)
  • FIG. 39 Resuscitators market, 2015 - 2026 (USD Million)
  • FIG. 40 Tracheostomy Tubes (TT) market, 2015 - 2026 (USD Million)
  • FIG. 41 Disposable oxygen mask market, 2015 - 2026 (USD Million)
  • FIG. 42 Pulse oximeters market, 2015 - 2026 (USD Million)
  • FIG. 43 Capnographs market, 2015 - 2026 (USD Million)
  • FIG. 44 Spirometers market, 2015 - 2026 (USD Million)
  • FIG. 45 Peak flow meters market, 2015 - 2026 (USD Million)
  • FIG. 46 Regional market place: Key takeaways
  • FIG. 47 Regional outlook, 2018 & 2026
  • FIG. 48 North America anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 49 U.S. anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 50 Canada anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 51 Europe anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 52 U.K. anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 53 Germany anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 54 France anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 55 Italy anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 56 Spain anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 57 Asia Pacific anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 58 Japan anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 59 China (Mainland) anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 60 India anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 61 Australia anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 62 South Korea anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 63 Latin America anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 64 Brazil anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 65 Mexico anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 66 Argentina anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 67 Colombia anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 68 MEA anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 69 South Africa anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 70 UAE anesthesia and respiratory devices market, 2015 - 2026 (USD Million)
  • FIG. 71 Strategy framework
  • FIG. 72 Market participant categorization
目次
Product Code: 978-1-68038-557-1

The global anesthesia and respiratory devices market size is expected to reach USD 49.4 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 6.6% over the forecast period. Increasing prevalence of respiratory diseases, patient preferences for reduced hospital stay, and supportive government funding are among the key driving factors.

Shifting preference of patients towards reduced hospital stay is anticipated to increase the adoption of anesthesia and breathing instruments, thereby, driving the market. As per the American Hospital Association, approximately 20% of Medicare beneficiaries, when discharged from hospital return within 30 days. Identifying and reducing avoidable readmissions is expected to improve healthcare safety and reduce spending. Hence, policymakers are striving to reduce hospital stays of patients. The Patient Protection and Affordable Act, Congress initiated the Hospital Readmission Reduction Program (HRRP) under which Medicare is allowed to penalize hospitals for higher rates of readmissions since 2013. Due to the implementation of this act, many physicians and patients opt for anesthesia and breathing devices, such as ambulatory infusion pumps and home respiratory monitors.

Furthermore, aging is considered one of the greatest risk factors for the development of sleep apnea disorders and is therefore, expected to be a high-impact rendering driver for this market.

Key players are also taking initiatives to develop advanced instruments with an aim to bring improvement in the treatment. For instance, in April 2018, B. Braun Medical Inc. announced to introduce Clorotekal, which is a U.S. Food and Drug Administration (FDA) approved anesthetics for spinal anesthesia. Such initiatives are anticipated to propel growth of the anesthesia and respiratory devices market in the forthcoming years.

Further key findings from the study suggest:

  • On the basis of product, respiratory devices is estimated to expand at the highest CAGR in terms of revenue over the forecast period owing to rising prevalence of cystic fibriosis, asthma, and tuberculosis. Positive airway pressure devices led the segment owing to increasing incidence of Obstructive Sleep Apnea (OSA)
  • Asia Pacific is expected to witness the fastest growth over the forecast period owing to increasing healthcare expenditure and awareness among patients

Few key players operating in the anesthesia and respiratory devices market are: AirSep Corporation; B. Braun Medical Inc.; BD; Medtronic; Drager; GE Healthcare; Philips Healthcare; ResMed; and Smiths Medical.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Information Procurement
    • 1.2.1. Purchased database
    • 1.2.2. GVR's internal database
    • 1.2.3. Secondary sources & third party perspectives
    • 1.2.4. Primary research
  • 1.3. Information Analysis
    • 1.3.1. Data analysis models
  • 1.4. Market Formulation & Data Visualization
  • 1.5. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Anesthesia and Respiratory Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Product Pipeline Analysis, by Stage
  • 3.4. User Perspective Analysis
    • 3.4.1. Consumer behavior analysis
    • 3.4.2. Market influencer analysis
  • 3.5. List of Key End-users, by Region/by Country/by Product
  • 3.6. Regulatory Framework
    • 3.6.1. Reimbursement framework
    • 3.6.2. Standards & compliances
  • 3.7. Market Dynamics
    • 3.7.1. Market driver analysis
      • 3.7.1.1. Shifting patient preference towards reduced hospital stay
      • 3.7.1.2. Supportive government funding in emerging markets
      • 3.7.1.3. Increasing global geriatric population base
      • 3.7.1.4. Technological advancements
    • 3.7.2. Market restraint analysis
      • 3.7.2.1. Lack of patient compliance
      • 3.7.2.2. Economic impact of respiratory disorders
    • 3.7.3. Industry challenges
      • 3.7.3.1.Harmful effects of the respiratory devices on neonates
  • 3.8. Anesthesia and respiratory devices: Market Analysis Tools
    • 3.8.1. Industry analysis - Porter's
      • 3.8.1.1. Supplier power: (Moderate): Presence of various major raw material suppliers
      • 3.8.1.2. Buyer power: (Moderate): Existence of insurance agencies focusing on cost reduction is expected to result in the consolidation
      • 3.8.1.3. Substitution threat: (Moderate): Introduction of technological advanced products
      • 3.8.1.4. Threat from new entrant: (Moderate): Complying with various regualtory bodies
      • 3.8.1.5. Competitive rivalry: (High): Dominated by few major players
    • 3.8.2. PESTEL analysis
      • 3.8.2.1 .Political Landscape
      • 3.8.2.2. Environmental Landscape
      • 3.8.2.3. Social Landscape
      • 3.8.2.4. Technology Landscape
      • 3.8.2.5. Legal Landscape
    • 3.8.3. Major deals & strategic alliances analysis
      • 3.8.3.1. Joint ventures
      • 3.8.3.2. Mergers & acquisitions
      • 3.8.3.3. Licensing & partnership
      • 3.8.3.4. Technology collaborations
      • 3.8.3.5. Strategic divestments
    • 3.8.4. Market entry strategies

Chapter 4. Anesthesia and respiratory devices Market: Segment Analysis, By Product, 2015 - 2026 (USD Million)

  • 4.1. Definitions & Scope
  • 4.2. Product Market Share Analysis, 2018 & 2026
  • 4.3. Segment Dashboard
  • 4.4. Global Anesthesia and respiratory devices Market, by Product, 2015 to 2026
  • 4.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
    • 4.5.1. Anesthesia devices
      • 4.5.1.1. Anesthesia machines
      • 4.5.1.1.1. Anesthesia workstation
      • 4.5.1.1.2. Anesthesia delivery machines
      • 4.5.1.1.2.1. Portable
      • 4.5.1.1.2.2. Standalone
      • 4.5.1.1.3. Anesthesia ventilators
      • 4.5.1.1.4. Anesthesia monitors
      • 4.5.1.2. Anesthesia disposables
      • 4.5.1.2.1. Anesthesia masks
      • 4.5.1.2.2. Anesthesia accessories
    • 4.5.2. Respiratory devices
      • 4.5.2.1. Respiratory equipment
      • 4.5.2.1.1. Humidifiers
      • 4.5.2.1.1.1. Heat humidifiers
      • 4.5.2.1.1.2. Heated wire breathing circuits
      • 4.5.2.1.1.3. Heat exchangers
      • 4.5.2.1.1.4. Pass over humidifiers
      • 4.5.2.1.2. Nebulizers
      • 4.5.2.1.2.1. Pneumatic nebulizers
      • 4.5.2.1.2.2. Mesh nebulizers
      • 4.5.2.1.2.3. Ultrasonic nebulizers
      • 4.5.2.1.3. Oxygen concentrator
      • 4.5.2.1.3.1. Fixed oxygen concentrators
      • 4.5.2.1.3.2. Portable oxygen concentrators
      • 4.5.2.1.4. Positive airway pressure devices
      • 4.5.2.1.4.1. Bi-level positive airway pressure devices
      • 4.5.2.1.4.2. Continuous positive airway pressure devices
      • 4.5.2.1.5. Reusable resucitators
      • 4.5.2.1.6. Ventilators
      • 4.5.2.1.6.1. Adult ventilators
      • 4.5.2.1.6.2. Neonatal ventilators
      • 4.5.2.1.7. Respiratory inhalers
      • 4.5.2.1.7.1. Dry powdered inhaler
      • 4.5.2.1.7.2. Metered dose inhaler
      • 4.5.2.2. Respiratory disposables
      • 4.5.2.2.1. Disposable oxygen masks
      • 4.5.2.2.2. Resuscitators
      • 4.5.2.2.3. Tracheostomy Tubes
      • 4.5.2.2.4. Oxygen Cannula
      • 4.5.2.3. Respiratory measurement devices
      • 4.5.2.3.1. Pulse oximetry systems
      • 4.5.2.3.2. Capnographs
      • 4.5.2.3.3. Spirometers
      • 4.5.2.3.4. Peak flowmeters

Chapter 5. Anesthesia and Respiratory Devices Market: Regional Market Analysis, By Region, 2015 - 2026 (USD Million)

  • 5.1. Definitions & Scope
  • 5.2. Regional Market Share Analysis, 2018 & 2026
  • 5.3. Regional Market Dashboard
  • 5.4. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
  • 5.5. Regional Market Share and Leading Players, 2018
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa
  • 5.7. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2025:
  • 5.8. North America
    • 5.8.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.8.2. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.8.3. U.S.
      • 5.8.3.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.8.4. Canada
      • 5.8.4.1.Market estimates and forecast, by product, 2015 - 2026 (USD Million)
  • 5.9. Europe
    • 5.9.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.9.2. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.9.3. Germany
      • 5.9.3.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.9.4. U.K.
      • 5.9.4.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.9.5. Italy
      • 5.9.5.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.9.6. France
      • 5.9.6.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.9.7. Spain
      • 5.9.7.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
  • 5.10. Asia Pacific
    • 5.10.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.10.2. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.10.3. India
      • 5.10.3.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.10.4. China
      • 5.10.4.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.10.5. Japan
      • 5.10.5.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.10.6. Australia
      • 5.10.6.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.10.7. South Korea
      • 5.10.7.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
  • 5.11. Latin America
    • 5.11.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.11.2. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.11.3. Brazil
      • 5.11.3.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.11.4. Mexico
      • 5.11.4.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.11.5. Argentina
      • 5.11.5.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.11.6. Colombia
      • 5.11.6.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
  • 5.12. Middle East and Africa
    • 5.12.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
    • 5.12.2. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.12.3. South Africa
      • 5.12.3.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.12.4. Saudi Arabia
      • 5.12.4.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)
    • 5.12.5. UAE
      • 5.12.5.1. Market estimates and forecast, by product, 2015 - 2026 (USD Million)

Chapter 6. Anesthesia and Respiratory Devices Market - Competitive Analysis

  • 6.1. Recent Developments & Impact Analysis, by Key Market Participants
  • 6.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2018
  • 6.4. Public Companies
    • 6.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
    • 6.4.2. Company market share/ranking, by region
    • 6.4.3. Competitive dashboard analysis
      • 6.4.3.1. Market differentiators
      • 6.4.3.2. Synergy analysis: Major deals & strategic alliances
  • 6.5. Private Companies
    • 6.5.1. List of key emerging companies/technology disruptors/innovators
    • 6.5.2. Funding outlook (Optional)
    • 6.5.3. Regional network map
    • 6.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
  • 6.6. Supplier Ranking
  • 6.7. Key Companies Profiled
    • 6.7.1. GE Healthcare
      • 6.7.1.1. Company overview
      • 6.7.1.2. Financial performance
      • 6.7.1.3. Product benchmarking
      • 6.7.1.4. Strategic initiatives
    • 6.7.2. Medtronic Plc
      • 6.7.2.1. Company overview
      • 6.7.2.2. Financial performance
      • 6.7.2.3. Product benchmarking
      • 6.7.2.4. Strategic initiatives
    • 6.7.3. Teleflex Incorporated
      • 6.7.3.1. Company overview
      • 6.7.3.2. Financial performance
      • 6.7.3.3. Product benchmarking
      • 6.7.3.4. Strategic initiatives
    • 6.7.4. Philips Healthcare
      • 6.7.4.1. Company overview
      • 6.7.4.2. Financial performance
      • 6.7.4.3. Product benchmarking
      • 6.7.4.4. Strategic initiatives
    • 6.7.5. Dragerwerk AG & Co. KGaA
      • 6.7.5.1. Company overview
      • 6.7.5.2. Financial performance
      • 6.7.5.3. Product benchmarking
      • 6.7.5.4. Strategic initiatives
    • 6.7.6. Getinge AB
      • 6.7.6.1. Company overview
      • 6.7.6.2. Financial performance
      • 6.7.6.3. Product benchmarking
      • 6.7.6.4. Strategic initiatives
    • 6.7.7. Smiths Group Plc
      • 6.7.7.1. Company overview
      • 6.7.7.2. Financial performance
      • 6.7.7.3. Product benchmarking
      • 6.7.7.4. Strategic initiatives
    • 6.7.8. Fisher & Paykel Healthcare Limited
      • 6.7.8.1. Company overview
      • 6.7.8.2. Financial performance
      • 6.7.8.3. Product benchmarking
      • 6.7.8.4. Strategic initiatives
    • 6.7.9. Masimo Corporation
      • 6.7.9.1. Company overview
      • 6.7.9.2. Financial performance
      • 6.7.9.3. Product benchmarking
      • 6.7.9.4. Strategic initiatives
    • 6.7.10. B. Braun Melsungen AG
      • 6.7.10.1. Company overview
      • 6.7.10.2. Financial performance
      • 6.7.10.3. Product benchmarking
      • 6.7.10.4. Strategic initiatives
    • 6.7.11. ResMed
      • 6.7.11.1. Company overview
      • 6.7.11.2. Financial performance
      • 6.7.11.3. Product benchmarking
      • 6.7.11.4. Strategic initiatives
    • 6.7.12. Charts Industries
      • 6.7.12.1. Company overview
      • 6.7.12.2. Financial performance
      • 6.7.12.3. Product benchmarking
      • 6.7.12.4. Strategic initiatives
Back to Top